TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer

NCT04475016 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Penile Cancer

Interventions

DRUG: Albumin-Bound Paclitaxel
DRUG: Ifosfamide
DRUG: Cisplatin
DRUG: Nimotuzumab
DRUG: Triprilimab

Sponsor

Sun Yat-sen University